Dyne Therapeutics receives FDA Priority Review for z-rostudirsen in DMD, with a potential U.S. launch in Q1 2027. DYN demonstrates best-in-class dystrophin expression in registrational trials, targeting a $3.5bn market for exon 51 skipping DMD patients. Robust pipeline includes z-basivarsen for DM1, with pivotal data expected Q1 2027 and potential accelerated approval/launch in 2028.
Barclays upgrades Lumentum stock to Overweight on Monday following a months-long selloff.
Ryanair Holdings plc (RYAAY) Q1 2027 Earnings Call Transcript
Bitcoin climbed back to $65,644 on July 20, capping a volatile three-day stretch shaped as much by chart levels as by the war between the United States and Iran. The move came after a hard drop on July 17, when BTC fell to $63,706 as U.S.
The XRP Ledger recorded a reversal in one of its most relevant usage indicators: the average number of transactions processed stopped declining and began recovering from local lows, sitting near 60 transactions according to recent network data. While the increase is modest in absolute terms, it represents an important trend reversal after weeks of sustained contraction in on-chain activity.
EVI faces near-term challenges from project delays and macro pressures, but its strong backlog, recurring service revenue and operational improvements support its long-term growth outlook.
Chamath Palihapitiya argues that Bitcoin faces 2 structural challenges, claiming speculative capital is shifting toward prediction markets while mining resources increasingly move into AI infrastructure. Bitcoin advocates reject the idea that these developments weaken Bitcoin's long-term fundamentals.
DoorDash expands its merchant network through Shopify and Dollar Tree deals as competition and tech investments pressure margins.
Microsoft Corp (NASDAQ:MSFT) is scheduled to report fiscal fourth-quarter earnings after the close on Wednesday, July 29.
Nvidia (NVDA) stock traded modestly higher on Monday, but investor attention is increasingly shifting toward the upcoming earnings season, where major technology companies are expected to provide fresh updates on artificial intelligence spending. Shares of the AI chipmaker rose 0.93% to $204.69 on Monday, although the gain trailed the 1.8% advance in the PHLX Semiconductor Index.
4D Molecular Therapeutics, Inc. maintains a Buy rating, driven by advancing 4D-150 gene therapy for Wet-AMD and DME into late-stage pivotal trials. FDMT's 4D-150 demonstrated up to 89% reduction in injection burden and maintained visual acuity over two years, with phase 3 topline data expected in 2027. Strong financial position with $458M cash and milestone payments, supporting operations into 2H 2028 and minimizing near-term dilution risk.
Investors interested in the Transportation sector can watch out for second-quarter 2026 earnings reports of LUV, CSX, UNP and AAL.
Stronger dollar put additional pressure on gold markets in today's trading session.
NLY's Q2 results, set to report on July 21, are likely to gain from higher NII and servicing income, while mortgage market volatility may pressure book value.
Sezzle Inc. SEZL entered 2026 with stronger customer engagement and a clear shift toward higher-value subscribers. In the first quarter of 2026, active subscribers rose 48.4% year over year to 714,000, while the combined total of monthly on-demand users and subscribers reached 887,000, up 34.8%.
PHM's Q2 results are likely to reflect higher sequential closings and resilient demand, even as lower prices, incentives and margin pressure weigh on earnings.
OranjeBTC repurchased 3.92 million shares for $3.11 million to increase Bitcoin per share, accelerating its dual capital allocation strategy on OranjeBTC repurchases 3.9 million shares for $3.11 million to boost Bitcoin per share.
GE Vernova Inc (NYSE:GEV) will report second-quarter earnings before the market opens on Wednesday, July 22.
On CNBC's Fast Money segment titled “A Big Tech Pullback
Bitfinex reports that Bitcoin closed three consecutive weeks in the green and is consolidating support above $61,360, with a key resistance level at $68,000. Flows into U.S. spot bitcoin ETFs have stabilized, though demand is concentrated almost exclusively in BlackRock's IBIT fund. U.S.
Memory stocks are catching a strong bid in Monday afternoon trading as the broader semiconductor complex rebounds from a rough stretch.
UroGen Pharma is shifting NMIBC treatment from surgery to office-based chemoablative therapy with ZUSDURI, driving a differentiated investment thesis. ZUSDURI revenue surged 109% sequentially to $29.2M in Q1 2026; repeat prescribers and workflow integration signal durable adoption and positive operating leverage. URGN's premium valuation is justified by a $5B+ TAM, durable clinical data, patent protection to 2044, and a de-risked pipeline including UGN-103.
The Zacks Electronics - Semiconductors industry players like AMAT, LRCX and FORM gain from the growing proliferation of AI that is driving sustained demand for advanced semiconductors.
RL is driving growth through women's apparel, outerwear and handbags, with premium categories supporting higher average selling prices.
AMC options surged out of the gate this morning with over 300,000 contracts traded as of writing.
Chip stocks rose on Monday as investors bought the dip following last week's rout.
Hackers have disabled Kenyan President William Ruto's official website, replaced its homepage and demanded a ransom of 5 Bitcoin. According to a report, the Kenyan government opened an investigation after attackers took control of president.go.
Stablecoins were supposed to make payment networks less necessary. Visa's new stablecoin platform, introduced Thursday (July 16), suggests a messier outcome.
The Zacks Internet - Content industry participants like OPRA and SMWB are benefiting from expanding mobile, digital and cloud-based offerings amid challenging global macroeconomic conditions.
TE Connectivity's fiscal third-quarter performance is expected to have benefited from strong order momentum, AI-driven demand, and backlog growth.